Primary Biliary Cirrhosis Drug Effective in Late-Stage TrialPrimary Biliary Cirrhosis Drug Effective in Late-Stage Trial

Intercept Pharmaceuticals said its experimental drug for primary biliary cirrhosis, obeticholic acid (OCA), was effective in a third late-stage clinical trial and that the results set the stage for the company to file for marketing approval. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news